NRINX | VSMAX | NRINX / VSMAX | |
Total Expense Ratio | 0.87 | 0.05 | 1,740% |
Annual Report Gross Expense Ratio | 0.87 | 0.05 | 1,740% |
Fund Existence | 6 years | 25 years | - |
Gain YTD | -7.041 | -3.912 | 180% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.04B | 148B | 1% |
Annual Yield % from dividends | 0.00 | 1.48 | - |
Returns for 1 year | -4.04 | 4.90 | -82% |
Returns for 3 years | 0.55 | 18.34 | 3% |
Returns for 5 years | 39.21 | 52.62 | 75% |
Returns for 10 years | N/A | 96.38 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DFEM | 28.72 | 0.11 | +0.38% |
Dimensional Emerging Markets Cr Eq 2 ETF | |||
SBIO | 31.02 | 0.09 | +0.29% |
ALPS Medical Breakthroughs ETF | |||
GAL | 46.29 | -0.08 | -0.17% |
SPDR® SSgA Global Allocation ETF | |||
DTRE | 39.98 | -0.09 | -0.23% |
First Trust Alerian Dsrupt Tech RE ETF | |||
IBDY | 25.44 | -0.06 | -0.24% |
iShares iBonds Dec 2033 Term Corp ETF |